Mydecine Innovations Group Inc. (AQU:MYIG)
London flag London · Delayed Price · Currency is GBP · Price in GBX
1.750
0.00 (0.00%)
Inactive · Last trade price on Mar 31, 2025
0.00%
Market Cap125.23K
Revenue (ttm)n/a
Net Income (ttm)-6.88M
Shares Outn/a
EPS (ttm)-0.12
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open1.750
Previous Close1.750
Day's Range1.750 - 1.750
52-Week Rangen/a
Betan/a
RSIn/a
Earnings DateMar 31, 2025

About AQU:MYIG

Mydecine Innovations Group Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. Its lead product drug candidates include MYCO-005. The company also develops MYCO-006 and MYCO-007. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entacto... [Read more]

Industry Agricultural Production Crops
Founded 2013
Country Canada
Stock Exchange Aquis Exchange
Ticker Symbol MYIG
Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements

News

There is no news available yet.